IL67930A - Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it - Google Patents

Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it

Info

Publication number
IL67930A
IL67930A IL67930A IL6793083A IL67930A IL 67930 A IL67930 A IL 67930A IL 67930 A IL67930 A IL 67930A IL 6793083 A IL6793083 A IL 6793083A IL 67930 A IL67930 A IL 67930A
Authority
IL
Israel
Prior art keywords
herpes simplex
simplex virus
vaccine composition
immunologically active
envelope glycoprotein
Prior art date
Application number
IL67930A
Other languages
English (en)
Other versions
IL67930A0 (en
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL67930(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Priority to IL80895A priority Critical patent/IL80895A/xx
Priority to IL80896A priority patent/IL80896A/xx
Publication of IL67930A0 publication Critical patent/IL67930A0/xx
Priority to IL80895A priority patent/IL80895A0/xx
Priority to IL80896A priority patent/IL80896A0/xx
Publication of IL67930A publication Critical patent/IL67930A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL67930A 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it IL67930A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination

Publications (2)

Publication Number Publication Date
IL67930A0 IL67930A0 (en) 1983-06-15
IL67930A true IL67930A (en) 1990-02-09

Family

ID=26996451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Country Status (20)

Country Link
US (1) US4762708A (fi)
EP (1) EP0101506B1 (fi)
JP (3) JP2665332B2 (fi)
KR (1) KR910006889B1 (fi)
AR (1) AR231496A1 (fi)
AT (1) ATE54827T1 (fi)
AU (1) AU554710B2 (fi)
CA (1) CA1236774A (fi)
DE (1) DE3381761D1 (fi)
DK (1) DK172619B1 (fi)
ES (1) ES519875A0 (fi)
FI (2) FI73885C (fi)
GR (1) GR77900B (fi)
HU (1) HU195734B (fi)
IE (1) IE56479B1 (fi)
IL (5) IL80896A (fi)
NO (2) NO162366B (fi)
NZ (1) NZ220771A (fi)
PH (1) PH25689A (fi)
WO (1) WO1983002897A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
ATE72123T1 (de) * 1985-04-19 1992-02-15 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
AU2001286407A1 (en) * 2000-08-01 2002-03-04 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds derived from the hsv gd protein and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
DK1523582T3 (da) * 2002-07-18 2009-03-02 Univ Washington Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
AU2004274430A1 (en) * 2003-09-12 2005-03-31 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
CA2663109A1 (en) * 2006-09-08 2008-03-13 The Trustees Of The University Of Pennsylvania Hsv-1 and hsv-2 vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
JP6144448B2 (ja) * 2006-12-28 2017-06-07 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 単純ヘルペスウイルス複合サブユニットワクチンおよびその使用方法
US9089537B2 (en) 2010-02-26 2015-07-28 The Trustees Of The University Of Pennslyvania Subunit vaccines for herpes viruses and methods of use
EP2694542A4 (en) * 2011-04-08 2014-10-08 Univ Duke HERPES SIMPLEX VIRUS
RS57420B1 (sr) 2012-05-16 2018-09-28 Immune Design Corp Vakcine za hsv-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
ES487106A0 (es) * 1978-12-22 1981-05-16 Biogen Nv Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv

Also Published As

Publication number Publication date
JPH0797396A (ja) 1995-04-11
DK172619B1 (da) 1999-03-01
FI833768A0 (fi) 1983-10-17
ES8406199A1 (es) 1984-08-01
JP2669594B2 (ja) 1997-10-29
FI83880B (fi) 1991-05-31
EP0101506B1 (en) 1990-07-25
NO172745B (no) 1993-05-24
WO1983002897A1 (en) 1983-09-01
JPS59500216A (ja) 1984-02-16
FI73885B (fi) 1987-08-31
IE830332L (en) 1983-08-18
FI73885C (fi) 1987-12-10
PH25689A (en) 1991-09-04
DE3381761D1 (de) 1990-08-30
AU554710B2 (en) 1986-08-28
IL80896A0 (en) 1987-03-31
DK479083D0 (da) 1983-10-17
JP2567202B2 (ja) 1996-12-25
ATE54827T1 (de) 1990-08-15
DK479083A (da) 1983-10-17
CA1236774A (en) 1988-05-17
NO162366B (no) 1989-09-11
KR910006889B1 (ko) 1991-09-10
HU195734B (en) 1988-07-28
FI83880C (fi) 1991-09-10
IL80895A0 (en) 1987-03-31
FI864102A0 (fi) 1986-10-10
JPH0769924A (ja) 1995-03-14
NO842962L (no) 1983-10-17
NO172745C (no) 1993-09-01
EP0101506A4 (en) 1984-07-06
ES519875A0 (es) 1984-08-01
FI864102A (fi) 1986-10-10
FI833768A (fi) 1983-10-17
IL80895A (en) 1990-02-09
IE56479B1 (en) 1991-08-14
US4762708A (en) 1988-08-09
IL67930A0 (en) 1983-06-15
NZ220771A (en) 1990-09-26
EP0101506A1 (en) 1984-02-29
NO833773L (no) 1983-10-17
IL80896A (en) 1990-02-09
AU1339683A (en) 1983-09-08
AR231496A1 (es) 1984-12-28
JP2665332B2 (ja) 1997-10-22
KR840003420A (ko) 1984-09-08
GR77900B (fi) 1984-09-25

Similar Documents

Publication Publication Date Title
IL67930A (en) Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
AU1255383A (en) Foot and mouth disease viral antigenic peptides
NZ217645A (en) Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
NZ205341A (en) 37 residue influenza virus peptide and vaccines
IL79954A0 (en) Attenuated pseudorabies virus and vaccine containing same
GR860987B (en) Antigens of the glycoprotein of the aids virus envelope specially of the glycoprotein precursors methods for obtaining these antigens means therefor and their applications
NZ203190A (en) Vaccines of infections bronchitis virus
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
AU4638085A (en) Therepautic preparations fortreatment of certain viral and other diseases and the preparation of the same
HK79890A (en) Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
IL60370A0 (en) Polyvalent virus vaccine and its preparation
GB8728000D0 (en) Immunologically active polypeptides useful for preparation of antimalarial vaccines and of diagnostic kits
IE830105L (en) Preparation of optically active mercaptoalkanoylaminoacids
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
DE2964881D1 (en) Parainfluenza virus vaccine and its preparation
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
AU553932B2 (en) Vaccine against herpes virus vaccine
ZA831097B (en) Materials and methods for herpes simplex virus vaccination
GB8730022D0 (en) Babesia divergens antigen & vaccine
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids
ZA88552B (en) Hiv gp160 aids virus envelope protein-containing strips and use thereof for detection of aids antibody
GB2125293B (en) Pharmaceutical preparation containing diaminodiphenylsulphone and brodimoprim
GB8712042D0 (en) Virus & vaccine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired